The most common treatment in Swedish healthcare in recent years has been drugs. Some 66 per cent of the Swedish population took prescription drugs in 2015.
As the Swedish population ages, the number of patients admitted to hospital increases, and in turn use of prescription drugs increases. This has significantly contributed to the incidence of drugs being poorly administered.
The consequences of mistakenly prescribed or consumed drugs can be severe, and figures on the number of deaths related to the inappropriate administering of drugs has increased in recent years: around six per cent of all deaths in Sweden are caused by the poor administering of drugs on behalf of patients.
Number of patients and prescriptions per year 2006-2015 (millions)
Number of deaths in Sweden 1997-2015 (thousands)
Another issue that has emerged with the growth of prescription drugs in healthcare is an increase in the number of patients who are treated outside hospital and therefore require external monitoring. A lack of personnel, time and resources has resulted in growing numbers of patients being monitored externally failing to take their medication or taking the wrong medication.
Technological innovation has resulted in homes becoming increasingly connected, and needing a new generation of products that better serve conventional requirements. The Swedish healthcare system has successfully encouraged the wider use of digitalisation in Sweden’s hospitals, but other areas of the healthcare system still need to be upgraded in certain ways to realise its full potential. MediRätt has identified this need and intends initially to direct its focus on those areas that are in acute need of improving efficiency through digitalisation. Smartphones have proven to be excellent tools that can be a great help in many aspects of individual’s daily lives. The launch of apps that are designed to increase patient knowledge is a smart and effective way to reach customer segments via a wider platform.
Improved awareness at the point when drugs are prescribed reduces the risk of drug-related illness and fatalities. Better results due to better quality builds trust in and understanding of the industry. Improvements and broadening of clinical trials offers more opportunities for better monitoring, wider collection of statistical data, and more efficient processes, thereby reducing lead times. The growth in patient knowledge contributes to transparency within the pharmaceutical industry, and gives actors new information channels with which to engage consumers and patients.
By implementing MediRätt’s products across healthcare organisations, hospital and healthcare staff can save time and resources linked to the control and follow-up of patients’ drug intake. Pill management becomes safer due to automation, and alerts can be sent in real time to ensure patient safety. Increased knowledge and understanding of drugs contributes to improved dialogue between healthcare professionals and patients, which in turn leads to reduced risk of mistakes when drugs are prescribed, and thereby a reduced incidence of illness and fatalities linked to the poor administration of drugs.
Reducing the risk of forgetfulness in patients increases patient safety and close relatives can effectively participate in and monitor patient care. Greater knowledge also contributes to lower risk of mistakes when drugs are purchased. MediRätt’s product, Dosell, can be filled with pre-packaged sachets containing all relevant pills as per patient requirements, and which are then delivered to patients or collected from pharmacies. The product’s patented design makes it easy for patients to take the right drugs at the right time. It also has a warning function that can be programmed to send alerts to responsible healthcare staff and/or close relatives.